FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160136469> ?p ?o ?g. }

• W2160136469 abstract "Tamoxifen is used for the treatment and prevention of ER (estrogen receptor)-positive BrCa (Breast Cancer). Several studies have shown that genetic variations in the CYP2D6 gene and/or drug-dependent inhibition of CYP2D6 enzyme activity (drug-drug interactions or DDIs) are associated with significant reductions in the circulating levels of endoxifen the active tamoxifen metabolite. These studies demonstrated that changes in CYP2D6 metabolism, as predicted from CYP2D6 genotyping, affect efficacy. Recent negative results with regards to CYP2D6 genotyping from two large studies suggest that testing for CYP2D6 status has no practical clinical value. Tumor DNA was used for genotyping in a large fraction of the BrCa patients in these studies. Genetic bias may result when CYP2D6 genotyping is carried out on the tumor (somatic) genome rather than the host genome (germline DNA) since it is the host genome that determines CYP450 enzyme activity within the liver and GI tract. Also expanded CYP2D6 polymorphism coverage, using a more comprehensive genotyping panel, may improve risk stratification when using CYP2D6 genotyping as a prognosticator in BrCa patients treated with tamoxifen. We hypothesize that BrCa tissues will harbor numerous mutations, due to a mutator phenotype inherent in most cancers, including within the CYP450 family of genes and, specifically, within the CYP2D6 gene. We expect that comparisons between germline DNA isolated from peripheral blood, and mutated DNA isolated from BrCa (somatic DNA) specimens within the same patient will reveal extensive differences in CYP2D6 genotypes. The aim of this study, is to extensively genotype 70 BrCa patients using a retrospective cohort with matched blood and tumor tissue from an existing biobank at UTHealth. We plan to perform genotype to phenotype conversions on each patient, for both germline and somatic DNA. We will look for discrepancies in genotypes and phenotypes and determine the magnitude of genetic bias possible in such cohorts. Method: DNA samples were extracted from matched archived tumor cells, dissected by laser microdissection microscopy and blood. Genotyping was performed by clinically validated Taqman® discrimination assays on the most common alleles for CYP2D6 . We also studied the genotype status of these paired samples for CYP2C9 , VKORC1 , Factor II , Factor V , MTHFR , CYP3A4 and CYP3A5 genes. CYP2D6 gene copy number and gene rearrangement with CYP2D7 pseudogene were also assessed by Taqman copy number assays at 3 three different sites within gene. Genotype-phenotype conversion was performed using an in-house developed, clinically validated genotype-phenotype translator package. Genotype agreement was assessed between the two DNA sources. Results : Noticeable non-concordant results between DNA from breast tumors and blood were observed in the genotyping of polymorphisms in the CYP2D6 gene. However, strong agreement between DNA from breast tumors and blood was detected in the genotyping of polymorphisms in all other studied genes. These results suggest that previous publications refuting the association between CYP2D6 genetic polymorphisms and tamoxifen efficacy could have reached an inaccurate conclusion due to genetic bias and study design. Further research in this biomarker area is needed. Citation Format: Mehdi Dehghani, Anneliese O Gonzalez, Neda Hashemi-Sadraei, Songlin Zhang, Kevin P Rosenblatt. Correlation between germline and tumor CYP450 2D6 gene polymorphisms [abstract]. In: Proceedings of the Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2014 Dec 9-13; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2015;75(9 Suppl):Abstract nr P5-10-09." @default.
• W2160136469 created "2016-06-24" @default.
• W2160136469 creator A5015231570 @default.
• W2160136469 creator A5044019108 @default.
• W2160136469 creator A5044427647 @default.
• W2160136469 creator A5078869143 @default.
• W2160136469 creator A5089828159 @default.
• W2160136469 date "2015-04-30" @default.
• W2160136469 modified "2023-09-27" @default.
• W2160136469 title "Abstract P5-10-09: Correlation between germline and tumor CYP450 2D6 gene polymorphisms" @default.
• W2160136469 doi "https://doi.org/10.1158/1538-7445.sabcs14-p5-10-09" @default.
• W2160136469 hasPublicationYear "2015" @default.
• W2160136469 type Work @default.
• W2160136469 sameAs 2160136469 @default.
• W2160136469 citedByCount "0" @default.
• W2160136469 crossrefType "proceedings-article" @default.
• W2160136469 hasAuthorship W2160136469A5015231570 @default.
• W2160136469 hasAuthorship W2160136469A5044019108 @default.
• W2160136469 hasAuthorship W2160136469A5044427647 @default.
• W2160136469 hasAuthorship W2160136469A5078869143 @default.
• W2160136469 hasAuthorship W2160136469A5089828159 @default.
• W2160136469 hasConcept C104317684 @default.
• W2160136469 hasConcept C109825262 @default.
• W2160136469 hasConcept C121608353 @default.
• W2160136469 hasConcept C13514818 @default.
• W2160136469 hasConcept C135763542 @default.
• W2160136469 hasConcept C2777176818 @default.
• W2160136469 hasConcept C31467283 @default.
• W2160136469 hasConcept C33664856 @default.
• W2160136469 hasConcept C501734568 @default.
• W2160136469 hasConcept C530470458 @default.
• W2160136469 hasConcept C54355233 @default.
• W2160136469 hasConcept C86803240 @default.
• W2160136469 hasConceptScore W2160136469C104317684 @default.
• W2160136469 hasConceptScore W2160136469C109825262 @default.
• W2160136469 hasConceptScore W2160136469C121608353 @default.
• W2160136469 hasConceptScore W2160136469C13514818 @default.
• W2160136469 hasConceptScore W2160136469C135763542 @default.
• W2160136469 hasConceptScore W2160136469C2777176818 @default.
• W2160136469 hasConceptScore W2160136469C31467283 @default.
• W2160136469 hasConceptScore W2160136469C33664856 @default.
• W2160136469 hasConceptScore W2160136469C501734568 @default.
• W2160136469 hasConceptScore W2160136469C530470458 @default.
• W2160136469 hasConceptScore W2160136469C54355233 @default.
• W2160136469 hasConceptScore W2160136469C86803240 @default.
• W2160136469 hasLocation W21601364691 @default.
• W2160136469 hasOpenAccess W2160136469 @default.
• W2160136469 hasPrimaryLocation W21601364691 @default.
• W2160136469 hasRelatedWork W2169491163 @default.
• W2160136469 hasRelatedWork W2185909900 @default.
• W2160136469 hasRelatedWork W2324394239 @default.
• W2160136469 hasRelatedWork W2333011089 @default.
• W2160136469 hasRelatedWork W2341324828 @default.
• W2160136469 hasRelatedWork W2411745829 @default.
• W2160136469 hasRelatedWork W2412224485 @default.
• W2160136469 hasRelatedWork W2515134348 @default.
• W2160136469 hasRelatedWork W2522084718 @default.
• W2160136469 hasRelatedWork W2559647210 @default.
• W2160136469 hasRelatedWork W2561623412 @default.
• W2160136469 hasRelatedWork W2595153636 @default.
• W2160136469 hasRelatedWork W2890128968 @default.
• W2160136469 hasRelatedWork W2899969480 @default.
• W2160136469 hasRelatedWork W3001927784 @default.
• W2160136469 hasRelatedWork W3031103351 @default.
• W2160136469 hasRelatedWork W3038182258 @default.
• W2160136469 hasRelatedWork W3135491144 @default.
• W2160136469 hasRelatedWork W2971661346 @default.
• W2160136469 hasRelatedWork W3031070245 @default.
• W2160136469 isParatext "false" @default.
• W2160136469 isRetracted "false" @default.
• W2160136469 magId "2160136469" @default.
• W2160136469 workType "article" @default.